Position in EVO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$53,475
-$56,835 QoQ
Shares Held
21,390
-40.3% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $1,964,785,401 across 53 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,199,799 | $229,937,554 | |
| 2 | VTRS |
Viatris Inc
|
13,564,872 | $215,410,166 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
6,129,240 | $207,658,650 | |
| 4 | HIMS |
Hims & Hers Health, Inc.
|
5,173,865 | $179,377,897 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
631,892 | $106,499,075 | |
| 6 | ALKS |
Alkermes plc.
|
2,023,984 | $106,056,760 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
814,096 | $90,315,809 | |
| 8 | UTHR |
UNITED THERAPEUTICS Corp
|
165,979 | $89,932,399 |
All Filings in EVO
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $53,475 | 21,390 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $110,310 | 35,815 | Shares | Defined | 2026-03-25 | |
| 2025-06-30 | $42,226 | 10,054 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $39,639 | 11,868 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $254,250 | 61,118 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $208,564 | 57,141 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $311,308 | 64,856 | Shares | Defined | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||